Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZyVersa Therapeutics, Inc.

0.1430
-0.0416-22.54%
Post-market: 0.14300.00000.00%16:00 EDT
Volume:635.47K
Turnover:98.27K
Market Cap:696.91K
PE:-0.02
High:0.1924
Open:0.1780
Low:0.1420
Close:0.1846
Loading ...
Sep 10, 2024

Correspondence

Form CORRESP - Correspondence
Sep 10, 2024

Correspondence

Form CORRESP - Correspondence
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 17, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 23, 2023

Major Issues Report

Form 8-K - Current report
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Correspondence

Form CORRESP - Correspondence
Dec 06, 2023

Correspondence

Form CORRESP - Correspondence